Alterity Therapeutics Ltd (ATH) — Long-term Investment Intensity

Latest as of June 2016: 0.1%

Alterity Therapeutics Ltd (ATH) has a Long-term Investment Intensity of 0.1% as of June 2016. Long-term investments of AU$43.99K represent 0.1% of total assets of AU$33.73 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Alterity Therapeutics Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

LT Investment Intensity

0.1%
LT Investments / Total Assets

Long-term Investments

AU$43.99K
AUD

Total Assets

AU$33.73 Million
AUD

Country

Australia
AU

Alterity Therapeutics Ltd Long-term Investment Intensity (2016–2016)

This chart shows how Alterity Therapeutics Ltd's Long-term Investment Intensity has evolved across 1 annual periods from 2016 to 2016. As of June 2016, the intensity stands at 0.1%, reflecting long-term investments of AU$43.99K against total assets of AU$33.73 Million AUD. Explore Alterity Therapeutics Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Annual Long-term Investment Intensity for Alterity Therapeutics Ltd (2016–2016)

The table below presents the year-by-year Long-term Investment Intensity for Alterity Therapeutics Ltd from 2016 to 2016, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see ATH market cap.

Year LT Investment Intensity LT Investments (AUD) Total Assets Change (pp)
2016 0.1% AU$43.99K AU$33.73 Million
pp = percentage points